R&D Can genetic data be a magic bullet for drug R&D? Drug development has long been an issue for the pharma industry, due to the expense and the high failure rate of potential treatments.
R&D Precision, speed, impact: Evolving mass spectrometry for med... MOBILion's Melissa Sherman explores the evolving role of mass spectrometry in drug discovery, complex molecule analysis, and medical research.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
